Skip to main content

BioXcel Therapeutics, Inc. (NASDAQ: BTAI) Investor Securities Class Action Lawsuit 07/07/2023

  • If you purchased a significant amount of shares of BioXcel Therapeutics, Inc. (NASDAQ: BTAI) between December 15, 2021 and June 28, 2023, and / or if you purchased any NASDAQ: BTAI shares prior to December 2021 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: September 5, 2023. NASDAQ: BTAI investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

July 07, 2023 - An investor in shares of BioXcel Therapeutics, Inc. (NASDAQ: BTAI) filed a lawsuit in the U.S. District Court for the District of Connecticut over alleged violations of Federal Securities Laws by BioXcel Therapeutics, Inc. in connection with certain allegedly false and misleading statements made between December 15, 2021 and June 28, 2023. New Haven, CT based BioXcel T...

You must register (for free) or login to view the entire case.